Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Feb 2022 for EQL Pharma AB, €34k.
Filing timeline
BuySalePer Svangren
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Per Svangren: trading record in brief
Only one filing by Per Svangren is known so far (18 February 2022): an open-market purchase, €34k, in EQL Pharma AB. That is too little to draw conclusions. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Per Svangren
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 10,000 shares@ SEK 35.4935100.0% of flowAktieISIN SE0005497732FI:csv-438ec1c2cd52654b2479Canonical exit: 18 May 2022 (T+90)
1 of 1 declaration